tiprankstipranks
Trending News
More News >
MAIA Biotechnology, Inc. (MAIA)
:MAIA
US Market
Advertisement

MAIA Biotechnology, Inc. (MAIA) Stock Statistics & Valuation Metrics

Compare
250 Followers

Total Valuation

MAIA Biotechnology, Inc. has a market cap or net worth of $49.49M. The enterprise value is $58.45M.
Market Cap$49.49M
Enterprise Value$58.45M

Share Statistics

MAIA Biotechnology, Inc. has 32,993,220 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,993,220
Owned by Insiders14.02%
Owned by Institutions1.89%

Financial Efficiency

MAIA Biotechnology, Inc.’s return on equity (ROE) is -6.40 and return on invested capital (ROIC) is -267.17%.
Return on Equity (ROE)-6.40
Return on Assets (ROA)-2.29
Return on Invested Capital (ROIC)-267.17%
Return on Capital Employed (ROCE)-2.68
Revenue Per Employee0.00
Profits Per Employee-1.79M
Employee Count13
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of MAIA Biotechnology, Inc. is ―. MAIA Biotechnology, Inc.’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value12.09
Price to FCF
Price to Operating Cash Flow-2.88
PEG Ratio

Income Statement

In the last 12 months, MAIA Biotechnology, Inc. had revenue of 0.00 and earned -23.25M in profits. Earnings per share was -1.05.
Revenue0.00
Gross Profit0.00
Operating Income-16.96M
Pretax Income-23.34M
Net Income-23.25M
EBITDA-16.96M
Earnings Per Share (EPS)-1.05

Cash Flow

In the last 12 months, operating cash flow was -15.77M and capital expenditures -5.00, giving a free cash flow of -15.77M billion.
Operating Cash Flow-15.77M
Free Cash Flow-15.77M
Free Cash Flow per Share-0.48

Dividends & Yields

MAIA Biotechnology, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.93
52-Week Price Change-52.70%
50-Day Moving Average1.66
200-Day Moving Average1.83
Relative Strength Index (RSI)42.83
Average Volume (3m)383.47K

Important Dates

MAIA Biotechnology, Inc. upcoming earnings date is ―, ―.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

MAIA Biotechnology, Inc. as a current ratio of 2.65, with Debt / Equity ratio of 0.00%
Current Ratio2.65
Quick Ratio2.65
Debt to Market Cap0.00
Net Debt to EBITDA0.57
Interest Coverage Ratio-297.49K

Taxes

In the past 12 months, MAIA Biotechnology, Inc. has paid -79.95K in taxes.
Income Tax-79.95K
Effective Tax Rate<0.01

Enterprise Valuation

MAIA Biotechnology, Inc. EV to EBITDA ratio is -2.03, with an EV/FCF ratio of -2.19.
EV to Sales0.00
EV to EBITDA-2.03
EV to Free Cash Flow-2.19
EV to Operating Cash Flow-2.19

Balance Sheet

MAIA Biotechnology, Inc. has $10.14M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$10.14M billion.
Cash & Marketable Securities$10.14M
Total Debt$0.00
Net Cash-$10.14M
Net Cash Per Share-$0.31
Tangible Book Value Per Share$0.16

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for MAIA Biotechnology, Inc. is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$14.00
Price Target Upside827.15% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast62.69%

Scores

Smart Score4
AI Score44
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis